Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte C Widemann

Showing results (51-60 of 203) with videos related to

Pageof 21
Sort By:
Neuro-Oncology|June 19, 2008
Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1Victor-F Mautner, Florence A Asuagbor, Eva Dombi, et al.
Neurology|July 11, 2018
Creating a comprehensive research strategy for cutaneous neurofibromasJaishri O Blakeley, Pierre Wolkenstein, Brigitte C Widemann, et al.
Blood|June 30, 2018
Improved CNS exposure to tocilizumab after cerebrospinal fluid compared to intravenous administration in rhesus macaquesAnandani Nellan, Cynthia M Lester McCully, Rafael Cruz Garcia, et al.
Journal of the National Cancer Institute|May 13, 2010
Pediatric phase I trial design using maximum target inhibition as the primary endpointHolly Meany, Frank M Balis, Alberta Aikin, et al.
Therapeutic Drug Monitoring|February 2, 2016
Population pharmacokinetics of sirolimus in pediatric patients with neurofibromatosis type 1-ErratumJeffrey R Scott, Joshua D Courter, Shannon N Saldaña, et al.
Therapeutic Drug Monitoring|May 14, 2013
Population pharmacokinetics of sirolimus in pediatric patients with neurofibromatosis type 1Jeffrey R Scott, Joshua D Courter, Shannon N Saldaña, et al.
The Journal of Pediatrics|December 11, 2013
Puberty and plexiform neurofibroma tumor growth in patients with neurofibromatosis type IUrania Dagalakis, Maya Lodish, Eva Dombi, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 6, 2024
Contemporary Approach to Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath TumorsAngela C Hirbe, Carina A Dehner, Eva Dombi, et al.
Frontiers in Endocrinology|November 17, 2022
Pediatric adrenocortical carcinomaMaran Ilanchezhian, Diana Grace Varghese, John W Glod, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|April 13, 2018
Improvement in Patient-reported Hearing After Treatment With Bevacizumab in People With Neurofibromatosis Type 2Victoria Huang, Amanda L Bergner, Chris Halpin, et al.
Pageof 21

Showing results (51-60 of 203) with videos related to

Sort By:
Pageof 21
Neuro-Oncology|June 19, 2008
Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1Victor-F Mautner, Florence A Asuagbor, Eva Dombi, et al.
Neurology|July 11, 2018
Creating a comprehensive research strategy for cutaneous neurofibromasJaishri O Blakeley, Pierre Wolkenstein, Brigitte C Widemann, et al.
Blood|June 30, 2018
Improved CNS exposure to tocilizumab after cerebrospinal fluid compared to intravenous administration in rhesus macaquesAnandani Nellan, Cynthia M Lester McCully, Rafael Cruz Garcia, et al.
Journal of the National Cancer Institute|May 13, 2010
Pediatric phase I trial design using maximum target inhibition as the primary endpointHolly Meany, Frank M Balis, Alberta Aikin, et al.
Therapeutic Drug Monitoring|February 2, 2016
Population pharmacokinetics of sirolimus in pediatric patients with neurofibromatosis type 1-ErratumJeffrey R Scott, Joshua D Courter, Shannon N Saldaña, et al.
Therapeutic Drug Monitoring|May 14, 2013
Population pharmacokinetics of sirolimus in pediatric patients with neurofibromatosis type 1Jeffrey R Scott, Joshua D Courter, Shannon N Saldaña, et al.
The Journal of Pediatrics|December 11, 2013
Puberty and plexiform neurofibroma tumor growth in patients with neurofibromatosis type IUrania Dagalakis, Maya Lodish, Eva Dombi, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 6, 2024
Contemporary Approach to Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath TumorsAngela C Hirbe, Carina A Dehner, Eva Dombi, et al.
Frontiers in Endocrinology|November 17, 2022
Pediatric adrenocortical carcinomaMaran Ilanchezhian, Diana Grace Varghese, John W Glod, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|April 13, 2018
Improvement in Patient-reported Hearing After Treatment With Bevacizumab in People With Neurofibromatosis Type 2Victoria Huang, Amanda L Bergner, Chris Halpin, et al.
Pageof 21